# Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma

> **NCT04776525** · PHASE2 · RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 49 (estimated)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Ifosfamide
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT04776525
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-27
- **Primary completion:** 2026-09
- **Final completion:** 2036-09
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776525, "Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04776525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*